Neuroprotection in Traumatic Brain Injury: Mesenchymal Stromal Cells can Potentially Overcome Some Limitations of Previous Clinical Trials

Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. In the last 30 years several neuroprotective agents, attenuating the downstream molecular and cellular damaging events triggered by TBI, have been extensively studied. Even though many drugs have shown promising resul...

Full description

Bibliographic Details
Main Authors: Marco Carbonara, Francesca Fossi, Tommaso Zoerle, Fabrizio Ortolano, Federico Moro, Francesca Pischiutta, Elisa R. Zanier, Nino Stocchetti
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2018.00885/full

Similar Items